Vandetanib
Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.
Product Specifications
CAS Number
443913-73-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
475.31
Molecular Formula
C22H24BrFN4O2
Notes
Research use only, not for human use.
Receptor
EGFR| VEGFR2| VEGFR3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog